2CV.F ConvaTec Group PLC

Healthcare Health Care Equipment & Supplies Frankfurt Exchange
2.84 EUR
Close of Nov 11, 2026
2.13 3.02
Market cap
EUR 5.43B
P/E
56.8x
P/B
4.26x
ROE
11.5%
Dividend yield
2.26%
Fundamental score
-

Ratios use the latest price and the fiscal year ending Dec 2025.

Is 2CV.F undervalued?

Graham number

The Graham number of ConvaTec Group PLC cannot be estimated reliably (the estimate is too far from the market price).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

ConvaTec Group PLC fundamental analysis

No fundamental analysis for ConvaTec Group PLC yet.

ConvaTec Group PLC stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About ConvaTec Group PLC

Convatec Group PLC engages in the development, manufacturing, and sale of medical products, services and technologies for the management of chronic conditions in Europe, North America, and internationally. The company offers advanced wound care products for the management of acute and chronic wounds resulting from various conditions, such as diabetes, and acute conditions resulting from traumatic injury and burns. It also provides ostomy care solutions, including devices, ac…

Full company profile